Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Li, Y., Li, G., Zhang, L., Li, Y
Disclosure of interest: All authors: nothing to disclose Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.02 - ACUTE MANAGEMENT - Thrombolysis or thrombectomy P717 - ESOC25-1757 NEUTROPHIL TO LYMPHOCYTE RATIO AND NEUROLOGICAL OUTCOMES IN ISCHEMIC STROKE AT 4.5 TO 24 HOURS: A POST HOC ANALYSIS OF TRACE-III TRIAL Manjun Hao 1 , Aoming Jin 2 , Yujie MA 1 , Zhixin Cao 1 , Liyuan Wang 1 , Shuangzhe Wu 1 , Yunyun Xiong 1,2 , Yongjun Wang 1,2 1 Beijing Tiantan Hospital, Capital Medical University, Beijing, China, 2 China National Clinical Research Center for Neurological Diseases, Beijing, China Background and Aims: The impact of Neutrophil to Lymphocyte Ratio (NLR) levels on the efficacy and safety of tenecteplase remains uncertain
It helps strengthen transparency, patient trust, and clinical communication
How BPC-157 Peptide Is Administered BPC-157 can theoretically be delivered several ways, but in a medical clinic like ours, the clinically relevant routes are two: subcutaneous injection and, in selected cases, oral capsules for gut-specific indications
